Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, AMPK and FOXO3a in MCF-7 breast cancer cells.
Recent studies have demonstrated that the anti-diabetic drug, metformin, can exhibit direct antitumoral effects, or can indirectly decrease tumor proliferation by improving insulin sensitivity. Despite these recent advances, the underlying molecular mechanisms involved in decreasing tumor formation...
Main Authors: | Eveline A I F Queiroz, Stephanie Puukila, Rosangela Eichler, Sandra C Sampaio, Heidi L Forsyth, Simon J Lees, Aneli M Barbosa, Robert F H Dekker, Zuleica B Fortes, Neelam Khaper |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4032293?pdf=render |
Similar Items
-
Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
by: Tamás Fodor, et al.
Published: (2016-01-01) -
Metformin inhibits cell proliferation in SKM-1 cells via AMPK-mediated cell cycle arrest
by: Xiaojia Zhou, et al.
Published: (2019-12-01) -
CHIP regulates AKT/FoxO/Bim signaling in MCF7 and MCF10A cells.
by: Yanrong Lv, et al.
Published: (2013-01-01) -
Metformin Attenuates ROS via FOXO3 Activation in Immune Cells
by: Jelka Hartwig, et al.
Published: (2021-04-01) -
Metformin, AMPK and Breast Cancer
by: Hadad, Sirwan Mohammed
Published: (2010)